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BACKGROUND PAPER
Challenges for clinical practice and research in family medicine in reducing
the risk of chronic diseases. Notes on the EGPRN Spring Conference 2017
in Riga
Vija Silinaa and Ruth Kaldab
aDepartment of Family Medicine, Riga Stradins University, Riga, Latvia; bInstitute of Family Medicine and Public Health, University of
Tartu, Tartu, Estonia
KEY MESSAGES
 Use of early intervention to reduce morbidity and mortality rates of non-communicable diseases should be
well justified to avoid harm.
 Educating both patients and clinicians on the harms and benefits of the early diagnosis interventions is
essential.
 Care of multimorbid patients’ needs better designed PHC based research.
ABSTRACT
Chronic diseases in most cases belong to the category of non-communicable diseases (NCDs),
which are the main cause of mortality globally. Cardiovascular diseases, diabetes, chronic
obstructive pulmonary disease and cancer are the four NCDs responsible for 82% of NCD deaths.
Prevention of NCDs implies health promotion activities that encourage healthy lifestyle and limit
the initial onset of chronic diseases. Prevention also includes early detection activities, such as
screening at-risk populations, as well as strategies for appropriate management of existing dis-
eases and related complications. Early intervention, reducing morbidity and mortality rates could
be an appealing idea for patients, physicians and governmental institutions but could also cause
harm. Healthcare is undergoing profound changes, and the role of technology in diagnostics
and management of chronic diseases in primary healthcare (PHC) is increasing remarkably.
However, studies show that the standards of care for chronic diseases and preventive care are
met by less than 50%. We still lack clear standards for patients with multiple chronic diseases.
The applicability of a single evidence-based guideline to multimorbid patients is limited and can
be problematic. Well-designed PHC studies focusing on the impact of medical interventions on
morbidity, mortality and quality of life in the fields of early diagnosis, early treatment and multi-
morbidity are still needed.
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The theme of the EGPRN Riga Conference held in May
2017 was ‘Reducing the risk of chronic diseases in gen-
eral practice/family medicine’. Chronic diseases in most
cases belong to the category of non-communicable
diseases (NCDs), which are the main cause of mortality
globally. Cardiovascular diseases (CVDs), diabetes,
chronic obstructive pulmonary disease and cancer are
the four main NCDs, altogether responsible for 82% of
NCD deaths.
Premature death is a major consideration when
evaluating the impact of NCDs on a given population
and is used as an indicator in the global monitoring
framework. Approximately 42% of all NCD deaths glo-
bally occur before the age of 70 years (48% in low-
and middle-income countries; 28% in high-income
countries). Cardiovascular diseases are responsible for
the largest proportion of NCD deaths under the age of
70 years (37%), followed by cancers (27%), chronic
respiratory diseases (8%) and diabetes (4%) [1]. The
probability of premature death (or probability of dying
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between the exact ages of 30 and 70 years) from the
four main NCDs is used to assess the extent of the
burden from mortality due to NCDs in the most eco-
nomically productive population [2]. It can also be
expressed as the percentage of 30-year-old people
who would die before their 70th birthday from cardio-
vascular disease, cancer, diabetes or chronic respiratory
disease, assuming that they would experience current
mortality rates at every age and would not die from
any other cause [3,4]. The probability of premature
deaths from the four main NCDs has decreased from
the year 2000 to 2015 both globally (from 22.7 to
18.8) and in the WHO European region (from 23.7 to
17.8). However, it varies a lot both among the WHO
European region countries (from 8% in Iceland to 35%
in Turkmenistan) and the European Union countries
(from 9% in Italy and Sweden to 24% in Bulgaria), as
shown in Figure 1 [5]. In 2013, approximately 2.5 mil-
lion potentially productive life years were lost due to
premature deaths from NCDs [6].
The prevention strategies for NCDs have been well
described. A comprehensive global monitoring frame-
work was adopted in 2013. It comprises nine targets
and 25 indicators across three areas, with a focus on
key outcomes, risk factors and national system
responses to the challenge of NCDs [2,7]. There are
four behavioural risk factors related to all four major
NCDs: tobacco use; unhealthy diet (high sodium, satu-
rated fat, trans-fat and sugar intake with low intake of
fruits and vegetables); physical inactivity (less than
150min of moderate intensity, or less than 75min of
vigorous intensity physical activity per week); and
harmful use of alcohol [2,7,8]. The WHO European
region has the highest prevalence of tobacco smoking
among adults and the highest total per capita alcohol
consumption among adults. The region shows a
reduction in levels of physical activity across all age
groups, has no countries meeting the WHO’s recom-
mended level of 2 g sodium/day (equivalent to 5 g
salt/day), and shows a steadily increasing prevalence
of overweight and obesity [3]. Other targets of the
framework include: relative reduction in risk of prema-
ture mortality from the four main NCDs; decreasing
prevalence of raised blood pressure; stopping the rise
in diabetes and obesity; implementing drug therapy
and counselling to prevent heart attacks and strokes;
improving availability of the affordable basic technol-
ogy and essential medicines required to treat major
NCDs [2].
Prevention is one of the primary healthcare (PHC)
tasks well known to both physicians and public.
Targets and quality criteria set for PHC teams, together
with NCD-related morbidity and mortality data that is
unfavourable, despite well identified primary and sec-
ondary prevention options [7], have encouraged the
EGPRN that the conference in Riga was devoted to
reducing the risk of chronic diseases in PHC.
This paper reflects on the ideas and research pre-
sented during the conference. First, we discuss some
uncertainties in prevention and early diagnosis, includ-
ing early cancer diagnosis and gut feelings. Later, the
gaps in multimorbid patient care are addressed.
Finally, we reflect on the potential use of general
practitioners’ (GPs) routine data to promote realistic
PHC-based studies.
Prevention and early diagnosis
The idea of early intervention to outpace the emer-
gence or progression of disease, and thus reduce
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Figure 1. Probability (%) of premature death (dying between age 30 and 70 years) from four main NCDs (cardiovascular diseases,
cancer, diabetes, chronic lung disease) in EU countries and in the WHO European region, data from 2015 [5].
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morbidity and mortality rates, seems appealing to
patients, physicians and governmental institutions.
This idea is included in the European Definition of
General Practice/Family Medicine. According to this
document, the family physician ‘promotes health
and well-being both by appropriate and effective
intervention’ [9]. However, non-required interven-
tions may cause harm, as well as waste valuable
healthcare resources [9]. An abundance of studies
supporting interventions, the trend to report posi-
tive findings and enthusiasm to apply the evidence
of every positive effect, especially as promoted by
secondary care specialists in their specific fields, can
lead to a situation in which the remark about
unnecessary interventions is neglected in real life.
Physicians tend to overestimate the benefits and
underestimate the harms of interventions [10].
Pressure from governmental institutions trying to fulfil
recommendations set by international organizations
(for example, NCD progress monitor indicators [11])
in primary care settings could add to this neglect.
Besides, a wrong or delayed diagnosis has been men-
tioned as one of the most common errors in primary
care [12,13]. The balancing of preventive and early
diagnostic intervention with the patient’s safety and
limited resources is a challenge in PHC. The best
available external evidence supports national targets
but the role of every individual GP and patient is
sometimes neglected. Evidence-based medicine (EBM)
has been defined as ‘conscientious, explicit, and judi-
cious use of current best evidence in making deci-
sions about the care of individual patients,’ and
integrates the best external evidence with individual
clinical expertise and the patients’ choices [14].
Respecting patients’ needs and expectations are par-
ticularly essential in primary care. As the majority of
patients tend to overestimate intervention benefit
and underestimate harm [15], it is crucial to educate
patients on the harms and benefits of the interven-
tions and to prepare them for inconclusive or unex-
pected test results to ensure that informed decisions
are made [16].
Early diagnosis of cancer
Cancer has been mentioned among the conditions
most related to incorrect diagnosis [12]. Analyses of
the results of widely implemented cancer screening
programmes have led to an extensive discussion about
overdiagnosis and overtreatment as threats to
patient’s safety. Unfortunately, at the individual level,
we can never be sure if the person is overdiagnosed
[17]. This brings even more uncertainty to a family
physician about what is right or wrong and how to
detect cancer early only in those patients who would
benefit from it.
Several studies and ideas related to the role of
different factors in early diagnostics of cancer were
presented at the EGPRN conference at Riga. Some
countries, for example, Latvia, are still struggling
with low cancer screening coverage rates. National
screening programme response rates in Latvia do
not exceed 50% for breast cancer and cervical can-
cer and 12% for colorectal cancer, despite the inclu-
sion of these rates in the quality criteria for family
physicians and the bonus payment for detecting first
and second-stage cancer [18]. Analysing the reasons
for the unwillingness of patients to participate (lack
of time being one of the most often mentioned rea-
sons), as well as implementing interventions in PHC
could improve the situation, as presented by Ivanova
et al. (Latvia) and Terjajeva et al. (Latvia) [19]. A
review presented by Le Reste et al. (France) argues
that colorectal cancer screening could be enhanced
by training methods that modify physicians’ behav-
iour and train them to enhance patient-centred care
communication instead of academic training meth-
ods [19].
Current knowledge on the potential harms of can-
cer screening programmes (particularly, false-positive
results and overtreatment) combined with dispropor-
tionate resources needed to implement them should
encourage more research and regular revision of such
programmes. The focus should be on tests and inter-
ventions with the most favourable harm–benefit and
cost-effectiveness ratios, as well as demand reasonable
time resources from both medical staff and patients
[16,17,20].
The €Oren€as Research Group study presented by
Harris M. [21] is working on the reasons for differences
in relative cancer survival rates in European countries,
which could be related to variations in how GPs act
when faced with patients that could have cancer. This,
in turn, is likely to be affected by how their healthcare
systems are organized. The group has elaborated a
validated questionnaire in 20 European languages to
evaluate what system factors affect GPs’ decisions to
refer patients for further investigation, how do these
compare across different European countries, and how
do they relate to one-year cancer survival rates. This
study will supplement the knowledge presented in a
study from the patient’s perspective in Denmark,
which implies that the organizational structure of
healthcare systems could influence care-seeking deci-
sions, and that further primary care research is neces-
sary [22].
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Gut feelings
To ensure that the right tests and procedures are
applied to the right (highest risk) patients, it is neces-
sary to understand what factors affect the family phys-
icians’ clinical expertise or ability to select the right
patients for diagnostic interventions. The ‘gut feeling’
could be described as intuitive fast thinking based on
familiar patterns and context [23]. A family physician is
an expert in recognizing patterns in their community
and should be able to use effectively their gut feeling
to select high and low-risk individuals. The presenta-
tion by Stolper et al. (Netherlands) indicated that gut
feelings of patients are respected by PHC team mem-
bers and they could influence a GP’s expertise and
diagnostic reasoning [19]. However, external evidence
on this issue still needs to be supplemented.
Care of multimorbid patients
When applying external evidence to chronically ill
patients with multimorbidity, the full definition of evi-
dence-based medicine [14] should be particularly kept
in mind. Besides, considering the differences in patient
care among GPs at both national and international lev-
els as demonstrated, for example, by Streit et al. [24],
research in chronic disease management performed in
the primary care setting is of utmost importance for
the improvement of our knowledge and exchange of
experience. The study implies that there is no real con-
sensus on the clinical definition and management of
frailty due to its complexity, which brings us back to
the need for adequate teaching and research in this
field.
The priorities for research include the general
practitioners’ understanding of frailty, the problems
with its care and cure as well as the understanding of
the biological and psychosocial basis of frailty and
evaluating the effects of therapeutic interventions.
Several presentations in the EGPRN conference at
Riga were related to multimorbid patient care, search-
ing for factors, which could affect the long-term care
of chronically ill patients. Lalande et al. (France) [21]
has found that age, frequency of family physician visits
and the extent of family difficulties were the factors
which predicted decompensation for multimorbid out-
patients. Odorico et al., (France) [21] argues that the
elderly in nursing homes decompensate more when
they suffer from pain or when their entourage does
not use coping strategies. Munoz et al. (Spain) [19]
points out that non-adherence to the prescribed meas-
ures and respiratory infections were most related to
heart failure decompensation in primary care settings.
Transfer of outer evidence to clinical practice is not
so straightforward. We still lack clear standards for
patients with multimorbidity. The applicability of a sin-
gle evidence-based guideline to multimorbid patients
is limited and can be problematic. A review including
10 studies shows that organizational interventions
which targeted specific risk factor management or
focused on areas where patients had more difficulties
(such as medicines management), were more likely to
be effective [25]. The NICE guideline from 2016 is the
only one that covers the care of adults with multimor-
bidity. The guideline committee has made many rec-
ommendations for research, such as clinical- and cost-
effectiveness of alternative approaches to organizing
primary care compared with usual care for people
with multimorbidity, as well as of stopping administer-
ing preventive medicines to people with multimorbidity
whomay not benefit from continuing them, etc. [26].
Use of GPs’ routine data for research
Further research focusing on the impact of medical
interventions on morbidity, mortality and quality of life
in the fields of early diagnosis, early treatment and
multimorbidity has to be encouraged. Reliable and
complete data form an essential part of the study. Use
of electronic health records (EHRs), including GPs’ rou-
tine data input in primary care settings, has broadened
the research capacities, as the digitalization era allows
EHRs to be combined to create much larger datasets
than would be feasible manually, facilitating biomed-
ical, epidemiological and public health research.
However, it also presents certain challenges. The need
to obtain informed consent could reduce the sample
size and lead to selection bias [25]. Secure de-identify-
ing of data for research purposes would solve the con-
fidentiality issue [27]. Selection and matching of data
from different databases in multicentre or international
studies, including those that are not specially designed
for research, is another challenge. Presentations by
Mada et al. (Romania) [19] and Majnaric et al. (Croatia)
[21] demonstrate the results of using EHRs’ data if
they have not been prepared explicitly for research.
Additionally, there is the challenge of de-identifying
the data provided by GPs so that they could be used
for diagnosis-specific studies both in primary and sec-
ondary care. Data could be particularly vulnerable in
the case of rare diseases or if the location of the
patient is known, as presented by Hauswaldt et al.
(Germany) [19]. De-identification is also a challenge
when data (for example, morbidity and mortality) are
analysed in small populations or communities, which
could be necessary if we would like to assess the
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probable impact of local environmental factors on
health.
Final remarks
Medicine and healthcare are undergoing profound
changes. Technological innovation combined with
automatization bring along exponential increase of
data production. However, what we are going to do
with the data? Can we synthesize useful information
from the ‘big’ data, transfer it to clinical practice and
put it into action when treating a single patient?
Alternatively, can we just talk and listen to the patient,
and try to understand the complexity and uniqueness
of each patient? This is a million-dollar question, which
deserves research.
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